Family Support Program for Critical Illness
Trial Summary
What is the purpose of this trial?
This trial tests EMPOWER, a psychological therapy designed to help family members who make medical decisions for critically ill patients in ICUs. The therapy aims to reduce grief and stress by teaching coping strategies that help people accept and manage their emotions. Researchers hope this will improve mental health outcomes and decision-making abilities for these family members.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on supporting decision-makers rather than changing medication regimens.
What data supports the effectiveness of the treatment EMPOWER for critical illness?
Research shows that the EMPOWER program, which is a cognitive-behavioral and acceptance-based treatment, helps improve mental health for those making medical decisions for critically ill patients. Similar programs, like COPE, have been effective in reducing stress and improving coping for parents of critically ill children, suggesting that EMPOWER may also be beneficial.12345
Is the Family Support Program for Critical Illness safe for humans?
How is the EMPOWER treatment different from other treatments for critical illness?
The EMPOWER treatment is unique because it is a cognitive-behavioral, acceptance-based intervention specifically designed for surrogate decision-makers of critically ill patients in the ICU. It focuses on improving both the mental health of the surrogates and the quality of life for patients, which is not typically addressed by standard medical treatments for critical illness.248910
Research Team
Wendy Lichtenthal, PhD
Principal Investigator
University of Miami
Holly Prigerson, PhD
Principal Investigator
Weill Medical College of Cornell University
Eligibility Criteria
This trial is for adult surrogate decision-makers of critically ill ICU patients near end-of-life. They must speak English, be able to use a device with internet, and live where the interventionist is licensed. Participants need to show significant pre-loss grief or distress but can't have cognitive impairments or recent suicidal ideation.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive the EMPOWER intervention or Supportive Conversation over a period of 3 months
Follow-up
Participants are monitored for changes in symptoms of PTSD, PGD, and other outcomes
Treatment Details
Interventions
- EMPOWER (Behavioral Intervention)
- Supportive Conversation (Other)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Weill Medical College of Cornell University
Lead Sponsor
Dr. Robert Min
Weill Medical College of Cornell University
Chief Executive Officer since 2024
MD, MBA
Dr. Adam R. Stracher
Weill Medical College of Cornell University
Chief Medical Officer since 2024
MD
National Institutes of Health (NIH)
Collaborator
Dr. Jeanne Marrazzo
National Institutes of Health (NIH)
Chief Medical Officer
MD from University of California, Los Angeles
Dr. Jay Bhattacharya
National Institutes of Health (NIH)
Chief Executive Officer
MD, PhD from Stanford University
National Institute of Nursing Research (NINR)
Collaborator
Dr. Jessica Gill
National Institute of Nursing Research (NINR)
Chief Medical Officer since 2023
PhD in Nursing from Johns Hopkins University
Dr. Shannon Zenk
National Institute of Nursing Research (NINR)
Chief Executive Officer since 2020
PhD in Urban Planning and Policy Development from Rutgers University